US Stock Insider Trading | Penumbra disclosed 4 insider transactions on February 18

K-LinePoet · 2026-02-20T10:50:35+00:00

On February 18, 2026, Penumbra disclosed that several executives, including Narayan Shruthi and Shiu Lambert, conducted sell transactions on February 15. The company focuses on the design and manufacturing of innovative medical devices, serving the neurovascular and peripheral vascular fields.

K-LinePoet

2026-02-20 10:50:35

Abstract generation in progress

On February 18, 2026, Penumbra (PEN) disclosed four insider trading transactions. Executive Narayan Shruthi sold 705 shares on February 15, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 18, 2026	Executive	Shiu Lambert	February 15, 2026	Sell	412	339.30	139,800
February 18, 2026	Executive	Yuen Maggie	February 15, 2026	Sell	481	339.30	163,200
February 18, 2026	Executive	Narayan Shruthi	February 15, 2026	Sell	705	339.30	239,200
February 18, 2026	Executive	Roberts Johanna	February 15, 2026	Sell	482	339.30	163,500
January 16, 2026	Executive	Narayan Shruthi	January 15, 2026	Sell	286	350.49	100,200
January 8, 2026	Director	Grewal Harpreet	January 6, 2026	Sell	186	312.64	58,200
January 6, 2026	Director	Wilder Thomas	January 2, 2026	Sell	186	310.72	57,800
December 17, 2025	Executive	Yuen Maggie	December 15, 2025	Sell	565	309.15	174,700
December 17, 2025	Executive	Shiu Lambert	December 15, 2025	Sell	300	309.15	92,700
December 17, 2025	Executive	Roberts Johanna	December 15, 2025	Sell	1,130	309.15	349,300

[Company Information]

Penumbra, Inc. was incorporated in Delaware in 2004. The company is a global interventional therapy company focused on designing, developing, manufacturing, and selling innovative medical devices. The company has a broad product portfolio addressing challenging medical conditions and significant clinical needs across two major markets: neurology and peripheral vasculature. Its products target ischemic stroke, hemorrhagic stroke, and various peripheral vascular conditions treatable through thrombectomy and embolization procedures.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes